L-carnitine is an amino acid produced by the body and found in some foods and supplements. It may offer some health benefits, including increased weight loss, improved brain function, and more.

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Revenue 25,774.09 22,753.12 21,763.34 19,159.59 ...

Return on investment - most recent fiscal year 16.16 ...

Cipla is recalling over 1,800 boxes of Lanthanum Carbonate chewable tablets in the US due to reports of broken tablets. The recall, classified as Class II, affects the medication used for high... Nov ...

Cipla's North American business achieved a record $250 million revenue in Q1 FY25, a 13% year-on-year growth. The company's branded prescription business in India grew 10%, while overall India growth ...

Cipla's current price is Rs 1488.40, showing a decline of 0.29% today. The 7-day exponential moving average stands at Rs 1490.33. Cipla is currently trading at Rs 1486.05, reflecting a 0.45% decrease ...

Apart from the above, the company also develops medicines to treat a few other conditions. With a market capitalization exceeding Rs.517 billion (7.9 billion USD), Cipla is reported to be one of the ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.